Authors: Brinster, C Muguet, S Lone, YC Boucreux, D Renard, N Fournillier, A Lemonnier, F Inchauspe, G

Citation: C. Brinster et al., Different hepatitis C virus nonstructural protein 3 (Ns3)-DNA-expressing vaccines induce in HLA-A2.1 transgenic mice stable cytotoxic T lymphocytes that target one major epitope, HEPATOLOGY, 34(6), 2001, pp. 1206-1217

Authors: Fournillier, A Wychowski, C Boucreux, D Baumert, TF Meunier, JC Jacobs, D Muguet, S Depla, E Inchauspe, G

Citation: A. Fournillier et al., Induction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sites, J VIROLOGY, 75(24), 2001, pp. 12088-12097

Authors: Renard, N Boucreux, D Lemonnier, F Inchauspe, G

Citation: N. Renard et al., HLA-A2 transgenic mouse model: potential utility for development of an HCVvaccine, J HEPATOL, 32(2), 2000, pp. 363-364

Authors: Vidalin, O Fournillier, A Renard, N Chen, M Depla, E Boucreux, D Brinster, C Baumert, T Nakano, I Fukuda, Y Liljestrom, P Trepo, C Inchauspe, G

Citation: O. Vidalin et al., Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki Forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens, VIROLOGY, 276(2), 2000, pp. 259-270